GL1X · GenesisL1 explorer

MolNFT v1 · #95105 · protein

High resolution crystal structure of human dihydroorotate dehydrogenase bound with 4-quinoline carboxylic acid analog

4IGH · Dihydroorotate dehydrogenase (quinone), mitochondrial: “High resolution crystal structure of human dihydroorotate dehydrogenase bound with 4-quinoline carboxylic…”. X-ray diffraction, 4 ligands (FMN, ORO, 1EA), 5 pockets (best…

PDB
4IGH
Type
protein
Length
356 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, 1EA, ZWI
Pockets
5 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein35645% helix, 17% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • 1EA · 6-fluoro-2-[2-methyl-4-phenoxy-5-(propan-2-yl)phenyl]quinoline-4-carboxylic acid · ligand · chains A
  • ZWI · 3-[decyl(dimethyl)ammonio]propane-1-sulfonate · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14530.840.9161FMN, ORO, 1EA
22210.630.8236ZWI
31560.500.7820empty
4750.430.8119GOL
51070.400.7621empty

Compared structures

  • 4IGH · High resolution crystal structure of human dihydroorotate dehydrogenase bound with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.